Sleep Disturbances clinical trials

Explore recruiting sleep disturbances clinical trials.

Recruiting sleep disturbances studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Sleep Disturbances trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

(22423 NIRVANA) A randomized, parallel-group treatment, Phase 2, double-blind pilot study to investigate the efficacy and safety of elinzanetant compared with placebo for treatment of sleep disturbances associated with menopause

Germany, Austria, Belgium, Netherlands, Poland, Czechia +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A phase IIa multicentre randomized controlled double blind clinical trial to demonstrate clinical efficacy on cognitive, neuropsychiatric and functional outcomes of Ambroxol in New and Early patients with prodromal and mild Dementia with Lewybodies (The ANeED study)

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

Cannabidiol in refractory childhood epilepsy, a personalized high-quality approach

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Repurposing mirtazapine in Rett syndrome: a multicentric open label Phase II study (MirtaRett Study).

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Cannabis extrAct in oncology Patients for the treatment of TUmor Related symptom burden (CAPTURE)

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Master protocol of two randomized, double blind, placebo-controlled, multi-center, parallel group studies to evaluate the efficacy and safety of dupilumab in adult patients with chronic pruritus of unknown origin (CPUO)

Hungary, Italy, Spain, Poland, Germany, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Sleep Disturbances trials by city

Sleep Disturbances in Toronto Sleep Disturbances in Vancouver Sleep Disturbances in Montreal Sleep Disturbances in Calgary Sleep Disturbances in Edmonton Sleep Disturbances in Ottawa Sleep Disturbances in Winnipeg Sleep Disturbances in Quebec City Sleep Disturbances in Hamilton Sleep Disturbances in Kitchener Sleep Disturbances in London Sleep Disturbances in Halifax Sleep Disturbances in New York Sleep Disturbances in Los Angeles Sleep Disturbances in Chicago Sleep Disturbances in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease